Skip to main content
Equibles
CBIO logo

CBIO · Crescent Biopharma, Inc. · Webcasts, Transcripts & Audio

Track CBIO — free

Use CBIO with AI

Add company filings, earnings and prices to ChatGPT or Claude, then ask questions in your own chat.

Choose your app for step-by-step connection instructions. Sign in with Equibles when asked; no code or API key is needed.

Claude ChatGPT

After connecting, ask your AI to use Equibles to research CBIO.

Other apps & server URL
https://mcp.equibles.com/mcp
Gemini CLI setup
or ask here

Free, nothing to set up — ALVIS runs on the same tools and cites every figure.

See what you can ask in ChatGPT or Claude

All connection guides →
$14.91 +0.79 (+5.59%) At close · Oct 9
Russell 2000 member Rebalance outlook locked
Market Cap
$553.82M
Shares
37.14M
Volume · Oct 9 347.15K Avg daily vol (3M) 398.47K

Crescent Biopharma, Inc. Webcasts

Earnings calls, investor updates, investor days and conferences for Crescent Biopharma, Inc. (CBIO), with available transcripts, audio replays and slides. Earnings calls also include available highlights, earnings releases and periodic filings.

Pull transcripts and briefs through the earnings call transcript API or MCP →

Revenue & result across quarters

Revenue Net income YoY up YoY down artefacts
▼88.3% $1.06M −$14.27M '21 Q1 21-05-03 · $142 −$14.40M '21 Q2 21-08-05 ▼91.3% $86,560 −$17.33M '21 Q3 21-11-02 · $17,624 −$17.42M '21 Q4 22-03-03 ▲52716.9% $75,000 −$13.27M '22 Q2 22-08-03 · $ −$15.15M '25 Q1 25-06-18 LATEST · $1.04M −$23.28M '26 Q1 26-05-26
Conference
Investor event
2026-09-14
Crescent Biopharma, Inc. (CBIO) September 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-08
Crescent Biopharma, Inc. (CBIO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Conference
Investor event
2026-06-03
Crescent Biopharma, Inc. (CBIO) June 2026 Conference Transcript
No reported result — non-financial event
Audio Transcript Slides
Earnings call
FY26 · Q1
2026-05-26
Crescent Biopharma, Inc. (CBIO) Q1 2026 Earnings Call
Revenue
$1.04M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY25 · Q1
2025-06-18
Crescent Biopharma, Inc. (CBIO) Q1 2025 Earnings Call
Revenue
$
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY24 · Q1
2024-05-06
Crescent Biopharma, Inc. (CBIO) Q1 2024 Earnings Call
Diluted EPS
$-4.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q4
2024-03-27
Crescent Biopharma, Inc. (CBIO) Q4 2023 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY23 · Q3
2023-11-03
Crescent Biopharma, Inc. (CBIO) Q3 2023 Earnings Call
Diluted EPS
$-14.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q2
2023-08-02
Crescent Biopharma, Inc. (CBIO) Q2 2023 Earnings Call
Diluted EPS
$-13.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY23 · Q1
2023-05-03
Crescent Biopharma, Inc. (CBIO) Q1 2023 Earnings Call
Diluted EPS
$-17.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q4
2023-03-29
Crescent Biopharma, Inc. (CBIO) Q4 2022 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY22 · Q3
2022-11-09
Crescent Biopharma, Inc. (CBIO) Q3 2022 Earnings Call
Diluted EPS
$-16.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q2
2022-08-03
Crescent Biopharma, Inc. (CBIO) Q2 2022 Earnings Call
Revenue
$75,000
▲ 52716.9% YoY
Diluted EPS
$-25.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY22 · Q1
2022-04-28
Crescent Biopharma, Inc. (CBIO) Q1 2022 Earnings Call
Diluted EPS
$-28.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q4
2022-03-03
Crescent Biopharma, Inc. (CBIO) Q4 2021 Earnings Call
Revenue
$17,624*
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-K
Earnings call
FY21 · Q3
2021-11-02
Crescent Biopharma, Inc. (CBIO) Q3 2021 Earnings Call
Revenue
$86,560
▼ 91.3% YoY
Diluted EPS
$-34.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q2
2021-08-05
Crescent Biopharma, Inc. (CBIO) Q2 2021 Earnings Call
Revenue
$142
Diluted EPS
$-28.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY21 · Q1
2021-05-03
Crescent Biopharma, Inc. (CBIO) Q1 2021 Earnings Call
Revenue
$1.06M
▼ 88.3% YoY
Diluted EPS
$-28.00
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q4
2021-03-02
Crescent Biopharma, Inc. (CBIO) Q4 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Earnings call
FY20 · Q3
2020-11-06
Crescent Biopharma, Inc. (CBIO) Q3 2020 Earnings Call
Revenue
$1.00M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q2
2020-07-31
Crescent Biopharma, Inc. (CBIO) Q2 2020 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-Q
Earnings call
FY20 · Q1
2020-05-01
Crescent Biopharma, Inc. (CBIO) Q1 2020 Earnings Call
Revenue
$9.00M
Rev · 8q Trailing quarterly revenue
Audio Transcript Slides 8-K10-Q
Earnings call
FY19 · Q4
2020-02-28
Crescent Biopharma, Inc. (CBIO) Q4 2019 Earnings Call
Results not yet reported
Audio Transcript Slides 8-K10-K
Showing 1–23 of 23 webcasts
Key facts CIK 1253689 CUSIP G2545C104 13F (30d) 3 filings 3 filers Visit website Investor relations